You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Safety of MSC therapy for IPF
|
|---|---|
| Published in |
Respirology, July 2014
|
| DOI | 10.1111/resp.12343 |
| Pubmed ID | |
| Authors |
Daniel C. Chambers, Debra Enever, Nina Ilic, Lisa Sparks, Kylie Whitelaw, John Ayres, Stephanie T. Yerkovich, Dalia Khalil, Kerry M. Atkinson, Peter M.A. Hopkins |
| Abstract |
Idiopathic pulmonary fibrosis (IPF) is a degenerative disease characterized by fibrosis following failed epithelial repair. Mesenchymal stromal cells (MSC), a key component of the stem cell niche in bone marrow and possibly other organs including lung, have been shown to enhance epithelial repair and are effective in preclinical models of inflammation-induced pulmonary fibrosis, but may be profibrotic in some circumstances. |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 1 | 14% |
| Unknown | 6 | 86% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 71% |
| Science communicators (journalists, bloggers, editors) | 1 | 14% |
| Practitioners (doctors, other healthcare professionals) | 1 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 166 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 1% |
| Japan | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 162 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 30 | 18% |
| Student > Ph. D. Student | 26 | 16% |
| Student > Master | 16 | 10% |
| Student > Bachelor | 15 | 9% |
| Other | 12 | 7% |
| Other | 26 | 16% |
| Unknown | 41 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 47 | 28% |
| Agricultural and Biological Sciences | 24 | 14% |
| Biochemistry, Genetics and Molecular Biology | 17 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 4% |
| Nursing and Health Professions | 5 | 3% |
| Other | 19 | 11% |
| Unknown | 48 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 March 2023.
All research outputs
#3,156,583
of 24,542,484 outputs
Outputs from Respirology
#423
of 2,890 outputs
Outputs of similar age
#30,576
of 230,875 outputs
Outputs of similar age from Respirology
#5
of 56 outputs
Altmetric has tracked 24,542,484 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,890 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 230,875 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.